Mylan, Inc., maker of the EpiPen and EpiPen Jr., have entered into a multi-state settlement, closing the case alleging they had knowingly overcharged taxpayers for the allergy injection drugs dispensed to Medicaid beneficiaries. Iowa Attorney General, Tom Miller, says the final settlement will include a $1.5 million payout to Iowa. “The facts of the case may be complicated, but the simple result is we’re holding Mylan accountable for deceiving our state’s Medicaid program in how the company charged for EpiPens,” Miller says. “While we allege Mylan overcharged the government, it really boils down to Mylan taking money from taxpayers that the company knew it wasn’t entitled to.” In this alleged misclassification, Mylan was able to pay lower state and federal rebates than it would have paid had it properly classified the drugs.
Most Recent Posts
Dozens of teachers and staff members from the Carroll Community School District (CCSD) hopped into more than 70 different vehicles Wednesday evening to wave at students they hadn’t seen in weeks due to the COVID-19 pandemic. The...Read More
Shirley Wenck, age 87, of Carroll passed away on Tuesday, March 31, 2020 at Swan Place in Carroll. A private funeral service will be held on Sunday, April 5, 2020 at the Dahn and Woodhouse Funeral Home...Read More
Officials with the Ar-We-Va Community School District are requesting parents and guardians to fill out a brief survey regarding students’ access to technology in the home to continue classes while schools are closed due to the COVID-19...Read More